Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant fusion protein-extracellular portion of CD95 fused to the Fc part of human IgG1 |
---|---|
Trade Name: | N/A |
Date Designated: | 10/13/2009 |
Orphan Designation: | Treatment of glioblastoma multiforme |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Marketing Approval Date: | N/A |
Approved Labeled Indication: | |
Exclusivity End Date: | N/A |
Sponsor: |
Apogenix GmbH Im Meuenheimer Feld 584 Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
-